Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Change in Accured Expenses (2016 - 2026)

Corcept Therapeutics' Change in Accured Expenses history spans 15 years, with the latest figure at -$9.4 million for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses fell 59.72% to -$9.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$3.4 million, a 39.76% decrease, with the full-year FY2025 number at $86000.0, down 99.31% from a year prior.
  • Change in Accured Expenses hit -$9.4 million in Q1 2026 for Corcept Therapeutics, up from -$17.1 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for CORT hit a ceiling of $17.2 million in Q3 2025 and a floor of -$17.1 million in Q4 2025.
  • Historically, Change in Accured Expenses has averaged $1.4 million across 5 years, with a median of $5.0 million in 2022.
  • Biggest five-year swings in Change in Accured Expenses: crashed 401.45% in 2022 and later surged 1261.22% in 2023.
  • Tracing CORT's Change in Accured Expenses over 5 years: stood at $802000.0 in 2022, then surged by 1261.22% to $10.9 million in 2023, then tumbled by 43.83% to $6.1 million in 2024, then plummeted by 378.51% to -$17.1 million in 2025, then skyrocketed by 45.09% to -$9.4 million in 2026.
  • Business Quant data shows Change in Accured Expenses for CORT at -$9.4 million in Q1 2026, -$17.1 million in Q4 2025, and $17.2 million in Q3 2025.